A Phase I/II Study of GW572016 in Patients With Recurrent Malignant Glioma.

Trial Profile

A Phase I/II Study of GW572016 in Patients With Recurrent Malignant Glioma.

Completed
Phase of Trial: Phase I/II

Latest Information Update: 28 Mar 2016

At a glance

  • Drugs Lapatinib (Primary)
  • Indications Glioblastoma
  • Focus Adverse reactions; Therapeutic Use
  • Most Recent Events

    • 24 Jan 2014 Actual end date changed from to 1 Jan 2011 to 1 Nov 2007 as reported by ClinicalTrials.gov record.
    • 26 Apr 2012 Actual patients number is 24 as reported by ClinicalTrials.gov.
    • 18 Jan 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top